Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: https://web.expasy.org/cellosaurus/CVCL_0417
Proper Citation: RRID:CVCL_0417
Description: Cell line MDA-MB-435 is a Cancer cell line with a species of origin Homo sapiens (Human)
Sex: Male
Disease: Amelanotic melanoma
Defining Citation: PMID:730202, PMID:7272986, PMID:9331090, PMID:10700174, PMID:10969801, PMID:11044355, PMID:15153330, PMID:15748285, PMID:17004106, PMID:17088437, PMID:17157791, PMID:18304946, PMID:19372543, PMID:19549886, PMID:20143388, PMID:20164919, PMID:22068913, PMID:22347499, PMID:22384151, PMID:22628656, PMID:23856246, PMID:23933261, PMID:24094812, PMID:24162158, PMID:24279929, PMID:24670534, PMID:25485619, PMID:25877200, PMID:26589293, PMID:27377824, PMID:27397505, PMID:27807467, PMID:28721362, PMID:28889351, PMID:28940260, PMID:31733513, PMID:38861359
Comments: Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000351). It was one of the sources for the STR profile of this entry., Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: JWGray breast cancer cell line panel., Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=18304946; PubMed=20143388; PubMed=28940260). Originally thought to originate from the pleural effusion of a breast carcinoma from a 31 year old patient. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line..
Category: Cancer cell line
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for MDA-MB-435.
Contaminated
Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=20143388; PubMed=28940260). Originally thought to originate from a breast carcinoma. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00235.
Contaminated
Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=18304946; PubMed=20143388; PubMed=28940260). Originally thought to originate from the pleural effusion of a breast carcinoma from a 31 year old patient. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00235.
Possibly Discontinued
Discontinued: ATCC; CRL-12583
Source: Cellosaurus
dkNET can assist you in preparing authentication plans for cell lines to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for the cell lines is based on the International Cell Line Authentication Committee (ICLAC)'s "Cell Line Checklist for Manuscripts and Grant Applications" and the example "Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating cell lines, check our Authentication Reports services.